These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20719983)

  • 21. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
    Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
    Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
    Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mouse model for immunogenic evaluation of human HBV vaccines.
    Guo Y; Ren D; He X; Wang F; Jiang L; Song S; He Y; Sun S
    Vaccine; 2009 Sep; 27(41):5692-9. PubMed ID: 19615480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination.
    Zhang W; Du X; Zhao G; Jin H; Kang Y; Xiao C; Liu M; Wang B
    Vaccine; 2009 Aug; 27(36):4938-46. PubMed ID: 19549606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study.
    Ganczak M; Szych Z; Korzeń M
    Vaccine; 2009 Jun; 27(30):3969-74. PubMed ID: 19389444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New perspectives for hepatitis B vaccines and immunization.
    Rapicetta M; D'Ugo E; Argentini C; Catone S; Canitano A; Giuseppetti R; Gluck R
    Vaccine; 2009 May; 27(25-26):3271-5. PubMed ID: 19200835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.
    Liu R; Lin Q; Sun Y; Lu X; Qiu Y; Li Y; Guo X
    Appl Biochem Biotechnol; 2009 Aug; 158(2):432-44. PubMed ID: 19184543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.
    Cruciani M; Mengoli C; Serpelloni G; Lanza A; Gomma M; Nardi S; Rimondo C; Bricolo F; Consolaro S; Trevisan M; Bosco O
    Vaccine; 2009 Jan; 27(1):17-22. PubMed ID: 18984022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.
    Nyström J; Cardell K; Björnsdottir TB; Fryden A; Hultgren C; Sällberg M
    Vaccine; 2008 Nov; 26(47):5967-72. PubMed ID: 18804140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination.
    Mizrahi M; Lalazar G; Ben Ya'acov A; Livovsky DM; Horowitz Y; Zolotarov L; Adler R; Shouval D; Ilan Y
    Vaccine; 2008 May; 26(21):2589-95. PubMed ID: 18423947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
    Ghebrehewet S; Baxter D; Falconer M; Paver K
    Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure.
    Huang ML; Liao WL; Ho MS
    Vaccine; 2007 Aug; 25(34):6326-33. PubMed ID: 17629600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
    Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
    World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of hepatitis B surface antigen in Saccharomyces cerevisiae utilizing glyceraldeyhyde-3-phosphate dehydrogenase promoter of Pichia pastoris.
    Vellanki RN; Komaravelli N; Tatineni R; Mangamoori LN
    Biotechnol Lett; 2007 Feb; 29(2):313-8. PubMed ID: 17136304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life.
    van der Sande MA; Mendy M; Waight P; Doherty C; McConkey SJ; Hall AJ; Whittle HC
    Vaccine; 2007 Feb; 25(8):1509-12. PubMed ID: 17095130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India.
    Shivananda ; Somani V; Srikanth BS; Mohan M; Kulkarni PS
    Clin Vaccine Immunol; 2006 Jun; 13(6):661-4. PubMed ID: 16760324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.